Barriers of thrombolysis therapy in developing countries
- PMID: 21603174
- PMCID: PMC3095908
- DOI: 10.4061/2011/686797
Barriers of thrombolysis therapy in developing countries
Abstract
The developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in developing countries. Until a cheaper thrombolytic agent and the proper infrastructure for utilization of thrombolytic therapy is available, developing countries should focus on primary and secondary stroke prevention strategies. However, governments and health systems of developing countries should efforts exerb for promotion of their infrastructure of stroke care.
References
-
- Feigin VL. Stroke epidemiology in the developing world. The Lancet. 2005;365(9478):2160–2161. - PubMed
-
- Ghandehari K, Izadi Mood Z. The Khorasan stroke registry: results of a five-year hospital-based study. Cerebrovascular Diseases. 2007;23(2-3):132–139. - PubMed
-
- Venketasubramanian N. Stroke in developing countries. In: Fisher M, Bogousslavsky J, editors. Current Review of Cerebrovascular Disease. 2nd edition. Philadelphia, Pa, USA: CM Publications; 2001. pp. 212–214.
-
- Ghandehari K, Izadi Mood Z. Cardioembolic strokes in Eastern Iran and the importance of rheumatic valvular disease. Turkish Journal of Medical Sciences. 2006;36(6):361–364.
-
- Ghandehari K, Izadi Mood Z. Incidence and etiology of ischemic stroke in Persian young adults. Acta Neurologica Scandinavica. 2006;113(2):121–124. - PubMed
LinkOut - more resources
Full Text Sources
